The activity of caspases is central to the apoptotic death of most cells. The Inhibitor of Apoptosis Proteins, or IAPs, serve as a last line of defense against caspase activity (reviewed in (1) . First discovered as viral proteins that inhibit host cell apoptosis after infection (2) , mammalian and insect IAPs have been found to modulate apoptosis activated by a large number of pathways. IAPs inhibit apoptosis, at least in part, by binding to caspases and inhibiting their function (3, 4) . Two Zn-binding domains define the IAP proteins: BIR domains and a ring domain. The BIR domains and nearby sequences are required to inhibit caspase function (5, 6) , while the ring domain is able to act as an E3 ubiquitin ligase (7) .
The antiapoptotic activity of IAPs is in turn inhibited by proapoptotic proteins that bind to the caspase binding site of the IAP BIR domains through a short conserved Nterminal motif, called the IAP Binding Motif or IBM (5, 6, (8) (9) (10) . Binding of IBM proteins to the IAP BIR domains blocks the caspase inhibitory function of the IAP (8, (10) (11) (12) . In Drosophila, the IBM containing proteins Reaper (Rpr), Hid, Grim and Sickle bind Drosophila IAP1 (DIAP1) (9, (13) (14) (15) (16) . Rpr, Hid and Grim act together to regulate most developmental apoptosis (17) . In the absence of these proteins, there is virtually no developmental apoptosis in the embryo. Expression of any one of these proteins induces rapid apoptosis, which is accompanied by the loss of DIAP1 (reviewed in (18) .
In the absence of DIAP1, most cells undergo rapid caspase dependent apoptosis. At least two mammalian proteins, SMAC/Diablo and Omi/HtrA2, also have IBM motifs
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and also bind to IAPs and inhibit their function (19) (20) (21) (22) (23) (24) (25) .
The IAP ring domain E3 ubiquitin ligase function has been implicated in both autoregulation of DIAP1 stability and the turnover of other proteins. Depending on the target, this E3 function can either inhibit or promote apoptosis. For example, mutations in the ring domain have been shown to stabilize DIAP1 (7, 26) . Increased DIAP1 is expected to promote survival, as the probability that cells will undergo apoptosis in response to a variety of proapoptotic stimuli is extremely sensitive to the levels of IAP (27) (28) (29) . DIAP1 is rapidly degraded in response to Hid or Rpr expression, and this loss is proposed to require E3 ligase activity (26, (30) (31) (32) (33) (34) . However, mutations in the ring domain of DIAP1 enhance rather than suppress killing by some apoptosis inducers in vivo (26, 28) . This indicates that a simple model where IBM protein binding stimulates DIAP1 degradation cannot explain the function of DIAP1 in vivo. In addition, DIAP1 is cleaved in apoptotic cells in response to Rpr expression (35) . The relationship between DIAP1 cleavage, DIAP1 degradation and inhibition of apoptosis is unclear.
The E3 ligase activity of the DIAP1 ring domain is also implicated in the degradation of the proapoptotic Rpr, Hid and Grim proteins, and degradation of caspases (26, (36) (37) (38) . These functions would be expected to inhibit apoptosis. Thus the E3 ligase activity of the ring domain may be both pro-apoptotic and antiapoptotic.
When all of these findings are taken together, IAPs seem to be able to perform a number of different functions in apoptosis that would have different outcomes in the (5, 6) . These caspases then act to promote DIAP1 degradation, providing a feed forward mechanism to amplify the proapoptotic signal.
In the mutant replacement system, as in previous assays, the DIAP1 ring domain was found to play an important role in DIAP1 turnover in living cells (26, (30) (31) (32) (33) (34) .
However, in dying cells, loss of ring domain function had little effect on Rpr-induced apoptosis. Hid-induced apoptosis was significantly inhibited by mutations in the ring domain, corresponding to what is seen in vivo (26, 28) . Finally, we find that mutations in the ring domain result in the persistence of the cleaved form of DIAP1, and this inhibits Hid-induced apoptosis.
The strength of this replacement assay system is best illustrated by the considerable correlation between the effects of DIAP1 mutations as assayed in this system and in vivo. Our data provide a more consistent picture of what happens to DIAP1 in dying cells. Taken together, our results allow us to understand what happens in cells as they begin to die, and suggest that the primary event in DIAP1 inactivation is displacement of the caspase, and that degradation of DIAP1 is a secondary event that is not required for apoptosis initiation. Finally, these data allow us to propose a model that explains how particular mutations in DIAP1 are able to specifically inhibit Rpr or Hid-induced apoptosis.
Results
In Drosophila, the initiation of apoptosis by Rpr or Hid is extremely rapid.
Expression of Rpr of Hid in the Drosophila embryo induces significant apoptosis within 1 to 2 hours (39, 40) . To understand how apoptosis is initiated by these proteins, we characterized the events at very early times after the induction of Rpr or Hid expression using an inducible expression system in S2 cells.
Effects of Rpr and Hid on endogenous DIAP1
To determine whether reduction in DIAP1 levels correlated with the initiation of death, we examined the fate of endogenous DIAP1 at short times after the induction of Rpr or Hid expression. We found that endogenous DIAP1 was very rapidly degraded in dying S2 cells (Fig 1) . Within 3 hrs of Rpr expression, all of the full length DIAP1 is gone. Hid induces DIAP1 loss at a somewhat slower rate, although by 3 hours almost all of the full length DIAP1 is lost. Caspase activation is dramatically elevated at this time (Fig. 1B) . We conclude that loss of full length DIAP1 is temporally correlated with the induction of apoptosis.
Previous work has demonstrated that DIAP1 is cleaved by caspases on induction of apoptosis by Rpr, Cyclohexamide and UV light (35) . We detected a single cleavage fragment of DIAP1 after apoptosis induction by Rpr or Hid. The appearance of this band was blocked by the addition of the caspase inhibitor zVAD-fmk or expression of the baculoviral caspase inhibitor p35 ( Fig. 1 and data not shown), indicating that the appearance of the band depends on the activity of caspases. In addition, mutation of a caspase cleavage site at D20 blocked the appearance of this band (see below), indicating that the smaller band corresponded to DIAP 21-438 (∆20 DIAP1) reported by Ditzel et al (35) .
We found that caspase activity was required for the loss of DIAP1 early in apoptosis. Addition of zVAD-FMK to the cultures blocked DIAP1 loss at 3 hours after apoptosis initiation by Rpr or Hid. This indicates that early in the induction of apoptosis, caspase activity is required for DIAP1 degradation. These data suggest that cleavage of DIAP1 at D20 activates DIAP1 degradation.
Evidence from numerous labs demonstrates that DIAP1 turnover is mediated by proteasome dependent degradation (26, (30) (31) (32) (33) (34) (31, 32, 34) . Apoptosis induction is seen to be very sensitive to the amount of DIAP1 in the cell (27) (28) (29) 41) .
Dissection of functional domains using a mutant replacement system
Both loss-of-function and gain-of-function mutations in DIAP1 were isolated as modifiers of Rpr and Hid-induced apoptosis in the Drosophila eye (27) (28) (29) . Many of these mutations affect domains of DIAP1 predicted to play a role in ubiquitin ligase function, or in binding to caspases or IBM proteins. We wanted to assay the effect of these mutations on DIAP1 degradation and on Rpr and Hid-induced apoptosis.
As demonstrated above, the S2 cell system is particularly useful to follow the fate of DIAP1 at early times after cell death induction. Although mutant forms of DIAP1 can easily be expressed in these cells, we found that overexpression resulted in a number of artifacts. For example, overexpression of wild type DIAP1 blocked or significantly delayed apoptosis induced by Rpr or Hid (data not shown). In addition, expression of some mutant forms of DIAP1 inhibited the normal apoptosis-associated loss of both the transfected and endogenous protein (data not shown).
To avoid these problems, we generated S2 cells that expressed only the transfected form of DIAP1. Endogenous DIAP1 was eliminated by RNA interference (RNAi) while relatively low levels of exogenous wild type or mutant DIAP1 were expressed from a UTR sequences. We generated dsRNA covering each of the predicted 5´ UTR exons, and to the 3´UTR ( Fig. 2A) . As a control, we used dsRNA to the coding sequence.
Endogenous DIAP1 in S2 cells is eliminated by dsRNA to one of the predicted 5´UTR exons (dsRNA b), and to the coding sequence (dsRNA e), and partially eliminated by dsRNA to the 3´UTR (dsRNA f) (Fig. 2B ). No endogenous DIAP1 can be detected after RNAi, even if apoptosis is prevented by the addition of caspase inhibitors (Fig. 2C ).
Both UTR dsRNA b+f and coding region dsRNA e induced significant apoptosis in cells (Fig. 2D ).
To express exogenous DIAP1, transfection constructs were generated that lacked DIAP1 5´UTR sequences. While coding region dsRNA e significantly knocked down expression of both exogenous and endogenous DIAP1, UTR dsRNA did not affect exogenous DIAP1 expression. In cells expressing exogenous wild type DIAP1, coding region dsRNA e induced apoptosis, while UTR dsRNA b+f did not (Fig. 2D ).
To assess the amount of DIAP1 expression on a single cell basis, we stained S2 cells by RNAi, but to be rapidly degraded in response to Rpr and Hid expression. In contrast, we expected that a loss-of-function mutant of DIAP1 would not protect against the loss of endogenous DIAP1.
The data shown in figure 3 confirmed this prediction. Cells were transfected with either wild type DIAP1 or DIAP1 carrying the th 7 mutation. The DIAP1 th7 mutation acts as a loss of function in vivo (28) . The mutation results in an in-frame deletion that leaves BIR1 and the ring domain intact, but eliminates most of BIR2 (Fig. 3A) .
Caspase activity was slightly elevated when endogenous DIAP1 was eliminated in cells expressing wild type DIAP1 exogenously ( Fig. 3D , E, green bars). This is probably due to the death of untransfected cells. In contrast, loss of endogenous DIAP1 in cells expressing the loss-of function mutation resulted in a significant increase in caspase activity. As seen in vivo, the presence of the ring domain and the BIR1 domain alone is
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not sufficient to inhibit apoptosis. In the absence of wild type DIAP1, the DIAP1 th7 mutant protein is rapidly cleaved in a caspase dependent manner ( This form has been noted by others (35) . Our model, presented below, predicts that this form of DIAP1 would be preferentially inhibitory to Hid-induced death.
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Neither expression of Rpr nor expression of Hid induces much further apoptosis in cells containing DIAP1 th7 . This suggests that caspase activation is already at maximal levels in these cells, and that many of the cells are already dead.
Role of the ring domain
The ring domain of DIAP1 plays a role in inhibiting apoptosis, by promoting the ubiquitination and degradation of proapoptotic proteins such as Rpr and the caspase Dronc (26, 37) . In addition, the ring domain promotes degradation of DIAP1, and this is able to promote apoptosis (reviewed in (42) . We assessed ring domain function by using our replacement assay to generate S2 cells that expressed only a mutant form of DIAP1 that lacked ring domain function: DIAP1 6B (6B) (28) . This C412Y mutation affects one of the cysteines that coordinate Zn in the ring domain (Fig. 4A) . A similar C406Y mutation has been shown to eliminate ubiquitin ligase function in DIAP1 21-4s
It is immediately obvious by western analysis that mutation of ring domain function stabilizes DIAP1 in living cells (Fig. 4B,C) . In order to visualize both wild type and DIAP1 6B expressing cells on the same western, we had to load half as much cell lysates from the cells expressing 6B. Not only was the full length form of DIAP1 (black arrow) stabilized by mutation of the ring domain, but also the cleaved form (green arrow) was stabilized to such an extent that it could now be detected in cells not In contrast to the slight decrease in Rpr-induced apoptosis, we found that Hidinduced apoptosis and loss of full length DIAP1 was very strongly suppressed by the presence of the 6B form of DIAP1 (Fig. 4E ). To compensate for the slower killing by Hid in this assay, we assessed Hid-induced caspase activation and DIAP1 levels at 3 hours and 4.5 hours after induction. Hid killing was suppressed in 6B expressing cells, even at these longer times. This also recapitulates the genetic interaction assayed in the adult eye, where the presence of a single copy of 6B suppresses Hid-induced cell death (26, 28) . To differentiate these models, we needed to inhibit DIAP1 degradation only in dying cells. As we have shown that caspase dependent cleavage of DIAP1 is required for DIAP1 loss early in apoptosis, we hypothesized that preventing caspase cleavage might inhibit DIAP1 loss. Using our mutant replacement system, we generated cells that only expressed DIAP1 carrying a mutation that prevented cleavage at the D20 site (Fig. 5A) . The D20A mutant form of DIAP1 was slightly more stable in living cells than wild type DIAP1, and apoptosis was effectively blocked after removal of endogenous DIAP1. These data indicate that cleavage at D20 is not required to prevent apoptosis.
DIAP1 degradation is not required to allow apoptosis
On induction of Rpr or Hid expression, D20A was significantly stabilized (Fig.5B,   C ). No ∆20 cleaved DIAP1 was visible, indicating that D20 is the main caspase cleavage site in DIAP1 in S2 cells.
Strikingly, we found that activation of caspase activity and induction of apoptosis were unaffected by mutation of the caspase cleavage site, despite the persistence of full 
Role of N-end rule degradation of DIAP1 ∆20
Previous work has indicated that the N-end rule degradation pathway contributes to the degradation of the ∆20 DIAP1 cleavage product (35) . This pathway can be activated by the presence of N-terminal destabilizing residues such as Asn, as is found on ∆20 DIAP1. A specific N-end rule E3 ligase is responsible for the ubiquitination of N-end rule degradation substrates (43) . However, as reported above, we find that loss of DIAP1 ring domain E3 ligase function stabilizes the ∆20 cleavage product.
To directly test the role of the destabilizing N-terminal residue in degradation of the DIAP1 ∆20, we expressed a mutant in which the destabilizing N was replaced by a stabilizing G. We found that this replacement slightly destabilized full length DIAP1.
Lower levels of DIAP1 resulted in a slight increase in apoptosis in cells that express N21G as the sole DIAP1, and slightly accelerated Rpr and Hid induced cell death ( Fig.   Yokokura et al  17 6 ). The ∆20 cleaved form of N21G DIAP1 is slightly more stable than the wild type ∆20
cleaved form. This is in contrast to the strong stabilization of ∆20 DIAP1 in living cells and dying cells when the ring domain is mutated. Taken with the previous findings, we interpret these data to indicate that the DIAP1 ring domain E3 ligase function is the major regulator of the degradation of cleaved DIAP1. The replacement assay was used to determine whether DIAP1 degradation is required for apoptosis initiation. We had found that cleavage was required for degradation. If caspase activity is inhibited, DIAP1 levels remain unaltered for a number of hours. Others have shown that caspase inhibition does not block DIAP1 degradation at much longer times after Rpr or Hid expression (32, 35) . It is not clear if this is relevant to normal Rpr-or Hid-induced apoptosis, which takes place within a few hours. We mutated the D20 caspase cleavage site, and found that this preserved full length DIAP1 after Rpr and Hid expression. However, apoptosis was unaltered in these cells. This strongly supports the idea that Rpr and Hid are able to displace caspases bound by DIAP1, rather than releasing caspases from DIAP1 inhibition after DIAP1 degradation. We also found that the E3 ligase function of the ring domain was required for the degradation of cleaved DIAP1.
Discussion

Most developmental apoptosis in Drosophila is
A model for apoptosis initiation by Rpr and Hid
We have developed a model for Rpr and Hid induced apoptosis that takes into account the findings reported here, and our earlier genetic data, along with data generated by a number of other labs (Fig. 7) . It is helpful in understanding the effects of the DIAP1 mutations on apoptosis.
In living cells, DIAP1 BIR2 is bound to an active form of Dronc, and inhibits the spontaneous initiation of apoptosis (5, 26, 45, 46) . DIAP1 turnover and Dronc turnover
Yokokura et al 19
are mediated by the activity of the DIAP1 ring domain (26, 30, 32, 33) . In the absence of active caspases, BIR1 binds to an auto-inhibitory domain in the N-terminus of DIAP1 (6).
When Rpr or Hid are expressed, they bind to the BIR2 domain of DIAP1 (47) . Dronc inhibition is released and DrICE and Dcp-1 are activated (46, 48) . DIAP1 is then cleaved at D20 by DrICE (our data and (6, 35) . This releases the N-terminal auto-inhibitory domain from BIR1, and allows BIR1 to bind active DrICE and Dcp-1 (6, 47) . The cleaved ∆20 fragment of DIAP1 is rapidly lost due to proteasome-mediated degradation. This loss depends in large part on the activity of the DIAP1 ring domain (our data). Hid is unable to bind BIR1 with high affinity (6, 47) . Thus when Hid is expressed, DrICE and Dcp-1 remain bound to the ∆20 fragment until it is degraded.
Rpr, on the other hand, binds to the BIR1 domain and is able to displace active DrICE/Dcp-1 (6, 47) .
A number of diverse observations support this model. For example, Rpr killing is much more rapid than Hid killing, and is accompanied by more rapid loss of full length DIAP1 (Fig. 4-6 ). This can be explained by the rapid displacement of active DrICE/Dcp-1 from the ∆20 fragment by Rpr. This active DrICE/Dcp-1 can go on to cleave more DIAP1. Also, a truncated form of DIAP1 present in transfected S2 cells as a result of translation initiation at an internal AUG selectively delays Hid killing, probably because it possess similar DrICE/Dcp-1 inhibitory activity to the ∆20
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fragment, which can not be relieved by Hid.
In addition, this model provides an explanation for some previously observed genetic interactions. Mutations in the DIAP1 ring domain specifically inhibit Hid killing (26, 28) . Based on our model, Hid is unable to release DrICE/Dcp-1 from the ∆20 fragment, which is present at high levels in the absence of ring-mediated degradation.
Rpr killing is unaffected by mutations in the ring domain (26, 28) , as the persistent ∆20 fragment is not inhibitory to Rpr. On the other hand mutations in the first BIR domain are specifically inhibitory for Rpr killing (28, 47) . In this case, Rpr is unable to displace DrICE/Dcp-1 from the ∆20 fragment (47) . This may slow Rpr killing significantly, while Hid killing is predicted to be unaffected. In vivo, Rpr may be extremely short lived (our data and (37). Therefore, slowing the process of Rpr-mediated DIAP1 inhibition could result in significant inhibition of Rpr killing. Finally, genetic interaction studies show that cell death induced by overexpression of Dcp-1 and DrICE is enhanced by Rpr expression, but not by Hid expression (49) . Our model suggests that this is due to the ability of Rpr to specifically displace Dcp-1 and DrICE from DIAP1 inhibition.
The inability of D20A DIAP1 mutants to inhibit caspase activation also supports our model. Both Rpr and Hid can displace active Dronc from inhibition by BIR2 in these mutants, despite the lack of cleavage or degradation. BIR1 inhibition by the N-terminal inhibitory domain is retained in these mutants, so DrICE/Dcp-1 activity is unchecked Yokokura et al 21 (6) . This may be responsible for the slight increase in Hid-induced apoptosis seen in the D20A mutant cells.
Role of the ring domain
In the absence of Reaper or Hid, the activity of the ring domain regulates the ubiquitination and proteasome-mediated degradation of both DIAP1 and Dronc (26, 30, 32, 33) . Our data confirm that mutation of the ring domain results in increased DIAP1 levels in living cells, demonstrating a role in DIAP1 turnover (Fig. 4) . In living cells, we also see high levels of the ∆20 form of DIAP1 6B . This strongly supports a role for the ring domain in degradation of this cleavage fragment. Our data do not support a major role for N-end rule mediated degradation of the ∆20 fragment in this system. DIAP1 inhibits Dronc by promoting ubiquitination and degradation of the protein (5, 26) . However, in vivo, ring domain activity is not essential to prevent apoptosis in S2 cells (Fig 4) . One possible explanation is that there is an increase in active Dronc in these cells, but most of the resultant DrICE/Dcp-1 effector caspase activity is inhibited by high levels of ∆20 DIAP1.
Hid induced death is strongly suppressed in S2 cells expressing 6B ring mutant DIAP1. This is predicted from our model, as the ∆20 DrICE/Dcp-1 inhibitory fragment is present at high levels in these cells. This DrICE/Dcp-1 inhibition cannot be relieved by Hid, and thus Hid killing is suppressed. This corresponds to what is seen in the Drosophila eye, where the presence of one copy of DIAP1 6B or DIAP1 81.03 , another mutation in the ring domain, suppressed Hid-induced death (26, 28) .
Rpr killing is also slightly suppressed in S2 cells expressing only the 6B protein.
This is unlike what is seen in vivo, where one copy of DIAP1 6B slightly enhances Rpr induced death in the eye (28) . This may be due to the presence of wild type protein in the eye disc of the heterozygotes acting to downregulate the stabilized 6B protein. In fact, we find that 6B/+ eye discs have similar level of DIAP1 protein to wild type discs (data not shown). In S2 cells expression of 6B alone results in very high levels of full length DIAP1, which may act to sequester some Rpr without activation of Dronc.
It is also possible that Rpr employs multiple mechanisms to inhibit DIAP1 activity.
At early times after strong expression of Rpr, displacement of Dronc followed by cleavage of DIAP1 and displacement of DrICE/Dcp-1 may be sufficient to kill cells.
However, if Rpr levels are not sufficient to induce rapid death, caspase-independent proteasome-mediated degradation of DIAP1, or inhibition of DIAP1 translation may contribute to the loss of DIAP1 and eventual apoptosis (30,33).
In sum, these studies provide new insight into the fate of DIAP1 during the initiation of apoptosis. We provide a model that synthesizes our findings with the findings of a large number of other labs, and allows us to explain some of the discrepancies between the genetic and biochemical data. It seems likely that this model
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can also be applied to understand the function of IAP proteins in other systems.
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Methods
Expression vectors
To express Rpr or Hid, the coding sequences were inserted into the pRmHa-3 vector (50) (pMT-Rpr or pMT-Hid). The DNA fragments encoding DIAP1 6B and DIAP1 th7 were obtained by PCR as described in previously (28), and inserted into pBluescript (Stratagene). DIAP1 D20A and DIAP1 N21G mutants were generated using site-directed mutagenesis with GeneTailor Site-Directed Mutagenesis System (Invitrogen). To express various form of DIAP1, the DIAP1 coding sequence with an Nterminal HA epitope tag was inserted into the pAc5.1 vector (Invitrogen) (pAc-DIAP1). 
Western analysis
Westerns were done as described in Wing et al (34) , except the anti-DIAP 1
antibody was used at 1:7500. Protein concentration was measured in lysates diluted 1:10 using the BCA protein assay kit (Pierce), following the manufacturer´s instructions.
Ten micrograms of each sample was mixed with 4X Laemmli Sample Buffer (200mM Tris pH 6.8, 8% SDS, 0.4% Bromophenol Blue, 40%Glycerol) and 100mM DTT and
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boiled for 5 minutes and analyzed on a 10%-Ready Gel Polyacrylamide gels (Bio-Rad).
Assay for Caspase Activity
The assay was performed essentially as described in Zimmerman et al (51) A) The N-terminal N of the ∆20 cleaved fragment was mutated to a G. This change has been reported to stabilize the degradation of this fragment by the N-end rule (35) . B, C)
The N21G mutation slightly destabilizes full length DIAP1 (black arrow) in RNAi 
